Novo Nordisk's pricing tactics from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of price gouging, stating the stark distinction in between U.S. charges and people in Europe and copyright.Novo Nordisk A/S is usually a Danish multinational pharmaceutical company headquartered in Bagsværd,[3]